Clinical Research Directory
Browse clinical research sites, groups, and studies.
Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Summary
Data about efficacy and safety of daratumumab in iTTP refractory or intolerant to standard immunosuppressive treatments are scarce. Therefore, the investigators aim at collecting evidence on a larger number of patients through a collaborative, international study.
Official title: DarTTP: an Observational, International, Multicentric Study on Daratumumab in Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
40
Start Date
2025-10-01
Completion Date
2026-08
Last Updated
2026-04-07
Healthy Volunteers
No
Locations (1)
Angelo Bianchi Bonomi Hemophilia and Thrombosis Center
Milan, Italy